All News

PharmaLex has announced the launch of a new service line, Biopharma Excellence, and appointed a new Chief Medical Officer.

With the headlines focused on COVID-19, many may have forgotten about the escalating epidemic of substance use disorder. National Recovery Month is a time to bring this issue back to the top of the agenda, raise awareness, and drive action, writes Richard Pops, CEO of Alkermes.

At this point of the evolving RWD landscape, we thought it appropriate to begin to broadly assess the use of real world data.

OM Pharma, active in the prevention of recurrent respiratory and urinary tract infections, wins the 2021 Geneva Economy Award.

Coupled with broader migration trends happening in the US, new upstart locations become increasingly attractive for investors, developers, tenants, and landlords.

Merck and Otsuka recognized for driving greater equality for women in the workplace.

FDA is launching a program to test the safety and suitability of novel inactive ingredients for use in new drugs and biologics.

17 abstracts highlighting safety and efficacy to be shared at upcoming conference.

Medical Information (MI) Contact Center services now deploy AI-powered virtual agents alongside skilled human agents to triage and respond to inquiries.

Funding will be used to further develop CC Bio’s microbiome editing technologies, which harness potent enzymes derived from bacterial viruses to seek out and destroy harmful and disease-causing bacteria.

Partnership pairs Aktana’s Contextual Intelligence Engine with Real Chemistry’s data and creative campaign.

Laura Steele will lead Lilly’s commercial business operations in six countries, across the company’s current and emerging portfolio in Diabetes, Oncology, Immunology and Neuroscience.

What can both public and private sector stakeholders learn from current trends to accelerate innovation around the COVID-19 pandemic and other emerging global health threats, including antimicrobial resistance?

New findings detail how executives handle compliance challenges.

Will oversee global acceleration and scaling of ZS’ portfolio of life sciences and healthcare work.

Novartis and the Novartis US Foundation have launched a 10-year commitment to co-create programs “that address the root causes of systemic disparities in health outcomes and create greater diversity, equity and inclusion across the research and development ecosystem.”

ProductLife Group has announced its acquisition of Czech Republic-based global regulatory outsourcing company, ELC Group.

Brand refresh aligns with company‘s purpose to enable healthcare organizations to be “future ready.”

Healthcare Businesswomen’s Association appointment ushers in a new chapter in its mission of advancing women in healthcare.

Pharma should be the ‘glue’ that bonds healthcare organizations together to solve society’s most pressing challenges.

Acquisition is largest in 37-year history of ZS.

California-based healthcare communications firm will be fully integrated into Fingerpaint.

New solution addresses pricing pressures and streamlines order-to-cash process.

What are the reasons behind the slump and what does the future hold?

The recent FDA approval of Biogen’s controversial drug aducanumab is the first drug approved for Alzheimer’s disease in nearly 20 years, and highlights the urgent need for new disease modifying approaches in drug development in this indication.

Janssen has launched series of videos and written perspectives on The Mighty, an online patient network, to highlight the stories of individuals living with pulmonary arterial hypertension (PAH).

It's time to apply the same COVID-19 urgency to other devastating diseases, such as Alzheimer’s, write Andrea Pfeifer and William Mobley.

NURTEC ODT approved for the preventive treatment of adult patients who experience less than 15 headache days per month.